Tracked deals
7
7 tracked deals across 2021-2025.
Cedar Knolls, New Jersey, United States
End-to-end life science commercialization solutions spanning the full spectrum of life sciences needs, including medical communications, branding/creative, and market access capabilities.
Tracked deals
7
7 tracked deals across 2021-2025.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Addon
5 addon · 2 buyout
Last 4 years
Supporting Data
Fingerpaint Group has acquired L&M Healthcare Communications, a New Jersey–based medical communications agency that serves biotech and pharmaceutical clients. The acquisition expands Fingerpaint Medical's medical communications and medical affairs capabilities; financial terms were not disclosed.
Fingerpaint Group announced its acquisition of BlackPoint Consulting Group, a specialized advisory firm based in New York City serving healthcare and life sciences companies. The deal strengthens Fingerpaint’s Market Access Center of Excellence by expanding its capabilities across market access and patient support for pharma clients. Financial terms were not disclosed.
Fingerpaint Group has acquired The MYND Group, a strategic market access marketing firm serving pharmaceuticals and biologics; financial terms were not disclosed. The acquisition expands Fingerpaint's market access and managed markets capabilities and is the company's second market access buy in three years as it continues to scale under PE partnership with Knox Lane.
Fingerpaint Group has acquired PharmaHEALTHLabs, a specialized healthcare communications agency focused on oncology and biologics, and will rebrand it as Fingerpaint Medical Communications. The acquisition deepens Fingerpaint's medical and scientific communications capabilities as part of its Specialty Services offering; financial terms were not disclosed.
Fingerpaint Group, a Knox Lane–backed healthcare marketing and specialty services platform, has acquired Parsons Medical Communications (PMC), a boutique scientific communications firm focused on the eyecare segment. The acquisition expands Fingerpaint's medical communications and eyecare capabilities; financial terms and seller details were not disclosed.
Fingerpaint Marketing, a Knox Lane–backed healthcare marketing agency, has acquired Emcay, a multicultural pharmaceutical marketing agency, and created Fingerpaint Multicultural to centralize Pharmacultural capabilities. Steve Millerman, former president of Emcay, will lead the new specialty offering reporting to Fingerpaint's head of marketing.
Fingerpaint, a biopharma commercialization partner, has acquired MedThink, a North Carolina–based medical communications firm, adding medical education, medical affairs communications, and publication services to its suite of capabilities. Financial terms were not disclosed; MedThink's president Scott Goudy will continue to lead day-to-day operations, and Knox Lane (a strategic investor in Fingerpaint) supported the transaction.
Turn tracked acquisition activity into an outreach-ready buyer list.